• What kind of business does your company engage in?

    We are a biotechnology company engaged in the research, development, and clinical testing of small‑molecule drug candidates, particularly in the oncology field.
    At present, our revenue is primarily derived from out‑licensed pipelines; however, looking ahead, we intend to pursue strategic partnerships that will enable us to advance toward in‑house manufacturing and commercialization.

  • What is the origin of your company name?

    The name Chordia is derived from the English word chord, meaning “harmony.”
    A chord consists of multiple notes resonating together to create a beautiful sound.
    Our name reflects the idea that the passion and tireless efforts of each member involved in drug discovery, combined with the support and goodwill of our external partners, come together like musical harmony—allowing us to efficiently deliver groundbreaking oncology therapies.